These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1636838)

  • 1. Use of cardiovascular disease medications and mortality in people with older onset diabetes.
    Klein BE; Moss SE; Klein R
    Am J Public Health; 1992 Aug; 82(8):1142-4. PubMed ID: 1636838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks Analysis.
    Baena-Díez JM; Peñafiel J; Subirana I; Ramos R; Elosua R; Marín-Ibañez A; Guembe MJ; Rigo F; Tormo-Díaz MJ; Moreno-Iribas C; Cabré JJ; Segura A; García-Lareo M; Gómez de la Cámara A; Lapetra J; Quesada M; Marrugat J; Medrano MJ; Berjón J; Frontera G; Gavrila D; Barricarte A; Basora J; García JM; Pavone NC; Lora-Pablos D; Mayoral E; Franch J; Mata M; Castell C; Frances A; Grau M;
    Diabetes Care; 2016 Nov; 39(11):1987-1995. PubMed ID: 27493134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure level and risk of major cardiovascular events and all-cause of mortality in patients with type 2 diabetes and renal impairment: an observational study from the Swedish National Diabetes Register.
    Afghahi H; Svensson MK; Pirouzifard M; Eliasson B; Svensson AM
    Diabetologia; 2015 Jun; 58(6):1203-11. PubMed ID: 25773403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess Mortality among Persons with Type 2 Diabetes.
    Tancredi M; Rosengren A; Svensson AM; Kosiborod M; Pivodic A; Gudbjörnsdottir S; Wedel H; Clements M; Dahlqvist S; Lind M
    N Engl J Med; 2015 Oct; 373(18):1720-32. PubMed ID: 26510021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between N-terminal prosomatostatin, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus (ZODIAC-35).
    van Dijk PR; Landman GW; van Essen L; Struck J; Groenier KH; Bilo HJ; Bakker SJ; Kleefstra N
    BMC Endocr Disord; 2015 Apr; 15():19. PubMed ID: 25880900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
    Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
    Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity is associated with lower mortality risk in elderly diabetic subjects: the Casale Monferrato study.
    Perotto M; Panero F; Gruden G; Fornengo P; Lorenzati B; Barutta F; Ghezzo G; Amione C; Cavallo-Perin P; Bruno G
    Acta Diabetol; 2013 Aug; 50(4):563-8. PubMed ID: 22068621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    Rawshani A; Rawshani A; Franzén S; Eliasson B; Svensson AM; Miftaraj M; McGuire DK; Sattar N; Rosengren A; Gudbjörnsdottir S
    N Engl J Med; 2017 Apr; 376(15):1407-1418. PubMed ID: 28402770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.
    Rådholm K; Chalmers J; Ohkuma T; Peters S; Poulter N; Hamet P; Harrap S; Woodward M
    Diabetes Obes Metab; 2018 Aug; 20(8):1903-1910. PubMed ID: 29603537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease.
    Salinero-Fort MÁ; San Andrés-Rebollo FJ; de Burgos-Lunar C; Abánades-Herranz JC; Carrillo-de-Santa-Pau E; Chico-Moraleja RM; Jiménez-García R; López-de-Andrés A; Gómez-Campelo P;
    J Diabetes Complications; 2016 Mar; 30(2):227-36. PubMed ID: 26627635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression and death in diabetes; 10-year follow-up of all-cause and cause-specific mortality in a diabetic cohort.
    Coleman SM; Katon W; Lin E; Von Korff M
    Psychosomatics; 2013; 54(5):428-36. PubMed ID: 23756124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8486 primary-care patients.
    Bodegard J; Sundström J; Svennblad B; Östgren CJ; Nilsson PM; Johansson G
    Diabetes Metab; 2013 Sep; 39(4):306-13. PubMed ID: 23871502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive models for all-cause and cardiovascular mortality in type 2 diabetic inpatients. A cohort study.
    Ramírez-Prado D; Palazón-Bru A; Folgado-de-la Rosa DM; Carbonell-Torregrosa MÁ; Martínez-Díaz AM; Gil-Guillén VF
    Int J Clin Pract; 2015 Apr; 69(4):474-84. PubMed ID: 25234387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland.
    Barnett KN; Ogston SA; McMurdo ME; Morris AD; Evans JM
    Diabet Med; 2010 Oct; 27(10):1124-9. PubMed ID: 20854379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Walking decreased risk of cardiovascular disease mortality in older adults with diabetes.
    Smith TC; Wingard DL; Smith B; Kritz-Silverstein D; Barrett-Connor E
    J Clin Epidemiol; 2007 Mar; 60(3):309-17. PubMed ID: 17292026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
    Bo S; Castiglione A; Ghigo E; Gentile L; Durazzo M; Cavallo-Perin P; Ciccone G
    Eur J Endocrinol; 2013 Jul; 169(1):117-26. PubMed ID: 23660643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal impairment and all-cause mortality in cardiovascular disease: effect modification by type 2 diabetes mellitus.
    Selvarajah S; Uiterwaal CS; Haniff J; van der Graaf Y; Visseren FL; Bots ML;
    Eur J Clin Invest; 2013 Feb; 43(2):198-207. PubMed ID: 23301500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midregional fragment of proadrenomedullin, new-onset albuminuria, and cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-30).
    Landman GW; van Dijk PR; Drion I; van Hateren KJ; Struck J; Groenier KH; Gans RO; Bilo HJ; Bakker SJ; Kleefstra N
    Diabetes Care; 2014; 37(3):839-45. PubMed ID: 24170764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27).
    Landman GW; Kleefstra N; Groenier KH; Bakker SJ; Groeneveld GH; Bilo HJ; van Hateren KJ
    Atherosclerosis; 2016 Jul; 250():46-51. PubMed ID: 27179179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care.
    Hippisley-Cox J; Coupland C
    BMJ; 2016 Jul; 354():i3477. PubMed ID: 27413012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.